Case of coexisting psoriatic arthritis and bullous pemphigoid improved by etanercept

Journal of Dermatology

Volumn 40, Issue 1, 2013, Pages 55-56

  Nin, Megumi ^a   Tokunaga, Daisaku ^a   Ishii, Norito ^b   Komai, Ayako ^b   Hashimoto, Takashi ^b   Katoh, Norito ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DAPSONE; ETANERCEPT; IMMUNOGLOBULIN G; PREDNISOLONE; AUTOANTIGEN; BIOLOGICAL MARKER; COLLAGEN TYPE 17; IMMUNOSUPPRESSIVE AGENT; NONFIBRILLAR COLLAGEN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTHRALGIA; BULLOUS PEMPHIGOID; CASE REPORT; HUMAN; KIDNEY DISEASE; LETTER; MALE; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RECURRENT DISEASE; REMISSION; VESICULAR RASH; ARTHRITIS, PSORIATIC; COMPLICATION; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MIDDLE AGED; PEMPHIGOID, BULLOUS; TREATMENT OUTCOME;

ARTHRITIS, PSORIATIC; AUTOANTIGENS; BIOLOGICAL MARKERS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 84872501716     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2012.01659.x     Document Type: Letter

References (12)

1. Menter A, Gottlieb A, Feldman SR, et al,. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008; 58: 826.
2. Gottlieb A, Korman NJ, Gordon KB, et al,. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for the treatment of with an emphasis on the biologics. J Am Acad Dermatol 2008; 58: 851.
3. Bloom D,. Psoriasis with superimposed bullous eruption. Med J Rec 1929; 130: 246-248.
4. Lazarczyk M, Wozniak K, Ishi N, et al,. Coexistence of psoriasis and pemphigoid-only a coincidence. Int J Mol Med 2006; 18: 619-623.
5. Grattan CEH,. Evidence of an association between bullous pemphigoid and psoriasis. Br J Dermatol 1985; 113: 281-283.
6. Chen YJ, Wu CY, Lin TJ, et al,. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study. Br J Dermatol 2011; 165: 593-599.
7. Salmhofer W, Kawahara Y, Soyer HP, et al,. A subepidermal blistering disease with Histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid? Br J Dermatol 1997; 137: 599-604.
8. Chang YT, Liu HN, Yu CW, et al,. Cytokine gene polymorphisms in bullous pemphigoid in a Chinese population. British J Dermatol 2005; 154: 79-84.
9. Cusano F, Iannazzone SS, Riccio G, et al,. Coexisting bullous pemphigoid and psoriasis successfully treated with etanercept. Eur J Dermatol 2010; 20: 520.
10. Yamauchi PS, Lowe NJ, Gindi V,. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol 2006; 54 (3 Suppl 2): S121-S122.
11. Saraceno R, Citarella L, Spallone G, et al,. A biological approach in a patient with psoriasis and bullous pemphigoid association with losartan therapy. Clin Exp Dermatol 2008; 33: 154-155.
12. Canizares MJ, Smith DI, Conners MS, et al,. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients. Arch Dermatol 2006; 142: 1457-1461.